AI in Healthcare
The latest on artificial intelligence transforming medicine
News stories discovered and organized by an automated pipeline. Covering clinical deployments, research breakthroughs, regulation, and industry developments.
Motif Neurotech Wins FDA IDE for Depression Implant Study
Motif Neurotech secured FDA IDE approval to begin a depression implant study, moving its neuromodulation program into clinical testing. The clearance is a key step for a field trying to translate brain-targeted hardware into durable psychiatric benefit.
The First Trial of Generative AI Therapy Shows It Might Help With Depression
MIT Technology Review examines the Dartmouth Therabot trial — the first rigorous test of generative AI for mental health treatment — and what its promising results mean for the future of therapy access.
First Randomized Trial of Generative AI Therapy Chatbot Shows Significant Mental Health Benefits
Dartmouth researchers conducted the first-ever randomized controlled trial of a generative AI therapy chatbot called Therabot. Participants with depression saw a 51% reduction in symptoms, while those with anxiety experienced a 31% reduction over four weeks.
How this works
Discover
An automated pipeline searches the web for significant AI healthcare news across clinical, research, regulatory, and industry domains.
Structure
The pipeline turns source material into concise, readable stories with categories, tags, and context that make the feed easier to scan.
Publish
Stories are deduplicated, stored, and published to this site. The pipeline runs automatically to keep coverage current.